SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : The Final Frontier - Online Remote Trading

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: TFF who wrote (342)10/6/1997 12:55:00 PM
From: John T. Hardee   of 12617
 
FMRX ready to break , This is there best product having great potential... OPERA innovative technology developed by FRMX addresses one of the most common women's healthcare issues today and underlines Tenet's commitment to building a leadership position in the field of women's health,'' said Michael H. Focht Sr., Tenet president and chief operating officer. ''Tenet is the first major healthcare provider to offer this minimally invasive alternative to hysterectomy on a system-wide basis.''
Abnormal uterine bleeding affects an estimated 10 million women, with up to 2 million seeking medical attention each year. The standard treatment for abnormal uterine bleeding has been hysterectomy. Approximately 600,000 hysterectomies are performed annually in the United States, making hysterectomy the second most common gynecological surgical treatment in the United States.

The FMRX, OPERA system is one of the most promising breakthrough technologies in the field of gynecology in several years,'' said Donna Shoupe, M.D., Service Chief, USC University Hospital. ''The OPERA instrumentation offers a safer, quicker and less expensive procedure for mainstream gynecologists to save a woman's uterus, which provides tremendous psychological and physical benefits to the patient.''

The OPERA procedure offers multiple advantages over other forms of treatment. The OPERA procedure can be performed on an outpatient basis that typically takes less than one hour. Unlike hysterectomy, which requires general anesthesia, OPERA can be performed under local anesthesia with sedation. Patients usually return home the same day and resume normal activity within three days, compared to an average two-to-four-day hospital stay and several weeks of recovery for a hysterectomy. Additionally, OPERA is estimated to be significantly less costly than a hysterectomy.

FMRX has produces for commercial use in the last 10 days two great products which will reduce the cost and time spent in a medical facility. As of this morning the news has only been reported on YAHOO. See FMRX in the double digits when things get rolling.

biz.yahoo.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext